1. Home
  2. SERA vs LNZA Comparison

SERA vs LNZA Comparison

Compare SERA & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SERA
  • LNZA
  • Stock Information
  • Founded
  • SERA 2008
  • LNZA 2005
  • Country
  • SERA United States
  • LNZA United States
  • Employees
  • SERA N/A
  • LNZA N/A
  • Industry
  • SERA Precision Instruments
  • LNZA Major Chemicals
  • Sector
  • SERA Health Care
  • LNZA Industrials
  • Exchange
  • SERA Nasdaq
  • LNZA Nasdaq
  • Market Cap
  • SERA 90.6M
  • LNZA 98.1M
  • IPO Year
  • SERA 2021
  • LNZA N/A
  • Fundamental
  • Price
  • SERA $3.15
  • LNZA $19.42
  • Analyst Decision
  • SERA
  • LNZA Hold
  • Analyst Count
  • SERA 0
  • LNZA 2
  • Target Price
  • SERA N/A
  • LNZA $200.00
  • AVG Volume (30 Days)
  • SERA 109.9K
  • LNZA 24.3K
  • Earning Date
  • SERA 11-05-2025
  • LNZA 11-07-2025
  • Dividend Yield
  • SERA N/A
  • LNZA N/A
  • EPS Growth
  • SERA N/A
  • LNZA N/A
  • EPS
  • SERA N/A
  • LNZA N/A
  • Revenue
  • SERA $108,000.00
  • LNZA $40,540,000.00
  • Revenue This Year
  • SERA $257.66
  • LNZA N/A
  • Revenue Next Year
  • SERA $435.22
  • LNZA $86.24
  • P/E Ratio
  • SERA N/A
  • LNZA N/A
  • Revenue Growth
  • SERA 0.94
  • LNZA N/A
  • 52 Week Low
  • SERA $1.37
  • LNZA $14.01
  • 52 Week High
  • SERA $9.13
  • LNZA $274.00
  • Technical
  • Relative Strength Index (RSI)
  • SERA 58.18
  • LNZA 37.33
  • Support Level
  • SERA $2.97
  • LNZA $19.07
  • Resistance Level
  • SERA $3.30
  • LNZA $20.77
  • Average True Range (ATR)
  • SERA 0.30
  • LNZA 1.13
  • MACD
  • SERA -0.00
  • LNZA 0.24
  • Stochastic Oscillator
  • SERA 57.46
  • LNZA 21.19

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

About LNZA LanzaTech Global Inc.

LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.

Share on Social Networks: